In the first 9 months, the total amount of electricity generated by CGN POWER(01816) was approximately 1721.79 billion kilowatt-hours, an increase of 3.17% year-on-year.
China General Nuclear Power Corporation (01816) announced that from January to September 2025, the group's total electricity generation from nuclear power units under operation and management reached...
CGN POWER (01816) announced that from January to September 2025, the total electricity generated by the nuclear power units operated and managed by the group was approximately 182.822 billion kilowatt-hours, an increase of 2.67% compared to the same period last year. The total electricity sent to the grid was about 172.179 billion kilowatt-hours, an increase of 3.17% compared to the same period last year.
In the third quarter of 2025, the group completed 4 annual fuel replacements and 1 initial fuel replacement according to plan.
As of September 30, 2025, the group has completed 12 annual fuel replacements (including 1 cross-year annual fuel replacement), 2 ten-year major maintenance projects, and 1 initial fuel replacement, as planned.
In the fourth quarter of 2025, in addition to continuing the ongoing fuel replacements, the group plans to start 2 new annual fuel replacements.
On July 14, 2025, Unit 6 in Lufeng completed dome lifting and entered the equipment installation phase.
On July 30, 2025, Unit 2 in Huizhou completed the hot functional test, laying a solid foundation for the unit's subsequent commercial operation.
On September 27, 2025, Unit 2 in Cangnan started the cold functional test and entered the debugging phase.
As of September 30, 2025, the group manages a total of 20 nuclear power units under construction (including 8 units managed by a company's controlling shareholder), with 4 units in the commissioning phase, 2 units in the equipment installation phase, 3 units in the civil construction phase, and 11 units in the preparation phase for fuel cycle division (FCD).
Related Articles

On October 14, Consun Pharma (01681) spent HK$4.8951 million to buy back 320,000 shares.

SIS INT'L (00529) will invest about 8.349 million Hong Kong dollars to acquire 50.01% stake in Gestetner and intends to make a mandatory tender offer to the remaining shareholders.

ALPHAMAB-B(09966) spent 3.9669 million Hong Kong dollars on October 14th to repurchase 293,000 shares.
On October 14, Consun Pharma (01681) spent HK$4.8951 million to buy back 320,000 shares.

SIS INT'L (00529) will invest about 8.349 million Hong Kong dollars to acquire 50.01% stake in Gestetner and intends to make a mandatory tender offer to the remaining shareholders.

ALPHAMAB-B(09966) spent 3.9669 million Hong Kong dollars on October 14th to repurchase 293,000 shares.

RECOMMEND